Bludigo
NDC 25021-840, Indigotindisulfonate Sodium, injection, from Sagent Pharmaceuticals.
- Product NDC
- 25021-840
- Status
- Listed
- Labeler
- Sagent Pharmaceuticals
- Dosage form
- INJECTION
- Route
- INTRAVENOUS
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- NDA
- Application
- NDA216264
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/25021-840 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- INDIGOTINDISULFONATE SODIUM8 mg/mL
Pharmacologic classes
Diagnostic Dye [EPC]; Dyes [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 25021-840-05 | 25021084005 | 5 AMPULE in 1 CARTON (25021-840-05) / 5 mL in 1 AMPULE |
Linked data
RxNorm, label and prices
RxNorm concepts
RxNorm links no concept to this product's packages.
Related lookups
FDA label sections
GET /v1/drugs/labels/2b91c39d-5f15-4dcf-9d3d-b378470e6bd7
Use it
Look up 25021-840 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/25021-840 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 25021-840. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.